Dr Kate Stringaris

Professional statement

Dr Kate Stringaris is a leading consultant haematologist and clinician scientist, renowned for her expertise in treating blood disorders, leukaemia and myelodysplastic syndrome. She also specialises in stem cells, immunotherapy and chronic lymphocytic leukaemia. She privately practises at HCA UK at University College Hospital while her NHS base is University College London Hospitals NHS Foundation Trust.
 
She obtained her primary medical degree from University College London and underwent general medical training at St George's Hospital before specialising in haematology at the Royal Free Hospital and Hammersmith Hospitals.

Dr Stringaris holds a PhD in Leukaemia from Imperial College London and is a senior clinical lecturer at St Bart's Hospital in London.

Throughout her career, Dr Stringaris has been actively involved in ground-breaking research on immune defects in leukaemia and transplantation immunology. As a senior research physician at the National Heart Lung and Blood Institute, part of the National Institutes of Health in the USA, she focused on stem cell therapies, natural killer cell immunity, and innovative immune therapies for acute myeloid leukaemia.

Dr Stringaris is dedicated to advancing the field of haematology through her research achievements, which have contributed significantly to improving patient outcomes. Her commitment to excellence has earned her recognition within the medical community, and she continues to be a member of professional organisations, further enhancing her expertise and staying at the forefront of advancements in haematology.

With her compassionate approach and unwavering dedication to patient care, Dr Kate Stringaris remains committed to providing the highest standard of treatment to individuals with blood disorders in London.